Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 20, No 3 (2024) A comparative study of circulating microRNA expression in blood in patients with coronary artery atherosclerosis and thoracic aortic aneurysm Abstract  similar documents
E. A.V. Ngo Bilong, S. V. Vasiliev, A. N. Rozhkov, D. A. Stonogina, D. Yu. Shchekochikhin, Y. I. Filippova, Ch. VK. Dzhafarova, N. P. Nurutdinov, A. V. Zhelankin, E. V. Generozov, A. S. Akselrod, Ph. Yu. Kopylov, A. L. Syrkin
"... . Significant differences between the pathology groups were noted for miR-126-3p and miR-205-5p. Some microRNAs ..."
 
Vol 18, No 6 (2022) Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants Abstract  similar documents
A. D. Aga, A. A. Sokolova, D. A. Napalkov
 
Vol 12, No 2 (2016) RESISTANT HYPERTENSION: THE AWARENESS OF DOCTORS AND THE EFFECTIVENESS OF THE COMBINATION THERAPY Abstract  similar documents
R. R. Kushkhova, A. G. Avtandilov, A. A. Pukhaeva
"... was made. A group of patients (n=126) with difficult to control hypertension 2-3 degrees, that internists ..."
 
Vol 12, No 5 (2016) The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin Abstract  similar documents
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
"... fibrillation (AF). Material and methods. Patients (n=126) older than 18 years, appealed to the Cardiology ..."
 
Vol 12, No 4 (2016) Morphometric changes of the left ventricle and characteristics of peripheral hemodynamics in patients with drug resistant hypertension Abstract  similar documents
R. R. Kushkhova, A. G. Avtandilov
"... in Group 1 was 150.02±10.7 g/m² vs 99.2±4.5 g/m² in Group 2 (p<0.001). LVMI in women in Group 1 was 126±7 ..."
 
Vol 16, No 2 (2020) The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, F. T. Ageev, G. S. Anikin, E. Kh. Akhmetzyanova, E. I. Bezuglova, A. B. Bekoeva, N. Yu. Borovkova, N. G. Vinogradova, E. V. Gorbunova, A. A. Goryacheva, E. S. Zhugrova, O. A. Kislyak, S. M. Klyashev, V. P. Kuzmin, A. A. Lipchenko, G. V. Matyushin, E. A. Mikhailova, V. A. Nevzorova, A. G. Obrezan, T. A. Petrichko, M. M. Petrova, A. N. Reider, A. N. Repin, V. I. Sadovoy, N. P. Sanina, A. E. Skripchenko, R. I. Stryuk, I. V. Faiyance, L. A. Khaisheva, N. R. Khasanov, R. A. Khokhlov, E. E. Tsareva, A. L. Cherkashina, I. I. Shaposhnik, I. A. Shelestova, R. N. Shepel, E. V. Shikh, D. A. Yakhontov
"... decreased from 162.7±12.6/94.3±7.9 mm Hg to 133.2±12.5/81.6±8.4 mmHg at the end of the 4th week and to 126 ..."
 
Vol 18, No 3 (2022) Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER Abstract  similar documents
I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk
"... =126; 58 men and 68 women; median age 60 (56.0; 65.5) years] examined. Patients were included into two ..."
 
Vol 12, No 6 (2016) EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... (from 107 [95;126.2] to 77 [67.2;99] cm/s; p<0.001) and in the portal vein (from 29 [20;31] to 19 [18 ..."
 
Vol 8, No 5 (2012) INFLAMMATORY REACTIONS IN EXPERIMENTAL MYOCARDIAL DAMAGE Abstract  similar documents
L. D. Khidirova, N. N. Mayanskaya
"... (from 5.5±0.03 to 12.6±1.23 pg/ml) and interleukin-1β (from 6.0±0.18 to 11.1±0.78 pg/ml). Conclusion ..."
 
Vol 16, No 2 (2020) Infectious Endocarditis in the Elderly – Comparative Study of Clinical Features, Course and Outcomes Abstract  PDF (Eng)  similar documents
N. S. Chipigina, N. Yu. Karpova, D. A. Anichkov, T. B. Kondratieva
"... and tumors of the genitourinary system or tumors of the gastrointestinal tract (OR=12.6; 95%CI 6 ..."
 
Vol 8, No 3 (2012) CARDIOTOXICITY ANTIPSYCHOTICS: MORPHO-ELECTROCARDIOGRAPHIC ASSOCIATIONS Abstract  similar documents
V. P. Volkov
"... .0±3.8% to 45.1±12.6% in groups 1 and 4, respectively), in specific volume of degenerative ..."
 
Vol 8, No 5 (2012) POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov, Kh. M. Raubzhanov
"... prophylactic propafenone therapy. Material and methods. Patients (n=63; aged 52.2±12.6 years; 25.4% women ..."
 
Vol 4, No 4 (2008) INFLUENCE OF ABDOMINAL OBESITY ON HEART STRUCTURAL AND FUNCTIONAL CHANGES AND POSSIBILITY OF THEIR PHARMACOLOGICAL CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. R. Veber, M. P. Rubanova, M. N. Kopina, S. V. Zhmajlova, D. P. Shmatko, I. V. Prozorova
"... with HT grade 2 were split in two groups. 124 women (aged 49,36±1,2 y.o.) and 126 men (aged 50,15±1,8 y ..."
 
Vol 18, No 2 (2022) Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure Abstract  PDF (Eng)  similar documents
V. I. Podzolkov, N. A. Dragomiretskaya, A. V. Kazadaeva, Yu. G. Belyaev, A. V. Tolmacheva
"... (9 [5.3; 12.6] ng/mL vs 11.8 [6.2; 15.3] ng/mL, p<0.05). According to the ROC-analysis data, galectin ..."
 
Vol 19, No 4 (2023) Biomarkers in predicting mortality from cardiovascular events in patients with heart failure and an implanted cardioverter-defibrillator Abstract  similar documents
N. N. Ilov, O. V. Petrova, D. K. Tverdokhlebova, I. R. Karimov, A. A. Nechepurenko, S. A. Boytsov
"... <60 ml/min/1,73 m2 and increased by 3,32 (OR=3,32; 95% CI: 1,26-8,73; p=0,012) at NT-proBNP >2000 pg ..."
 
Vol 13, No 5 (2017) THE ROLE OF FACTORS AFFECTING THE FORMATION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION Abstract  similar documents
M. V. Kurkina, A. G. Avtandilov, I. A. Krutovcev
"... – 125.9±27.4 g/m2, in the third group – 121.5±15.6 g/m2 and in the fourth one – 126.1±11.5 g/m2 ..."
 
Vol 9, No 5 (2013) ASSESSING FACTORS THAT FORM PATIENT’S ATTITUDE TO TREATMENT PRECEDING HOSPITALIZATION FOR ACUTE CORONARY SYNDROM (DATA OF QUESTIONNAIRE WITHIN THE LIS REGISTER) Abstract  PDF (Eng)  similar documents
Yu. V. Lukina, M. L. Gynzburg, V. P. Smirnov, S. Yu. Martsevich, N. P. Kutishenko, A. V. Fokina, E. V. Daniels
"... range was between 31 and 89 years, mean age was 63.6±12.6 years. Acute myocardial infarction ..."
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... , the contribution these drugs intake on hospital mortality was not identified. 272 patients (mean age 63.6±12.6 ..."
 
Vol 8, No 1 (2012) GENDER DISTINCTIONS OF MICROALBUMINURIA AND ITS RELATION TO INTRARENAL HEMODYNAMIC AND LEPTIN LEVEL IN ARTERIAL HYPERTENSION Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, J. N. Rodionova
"... than those without MAU: 126±32.5 vs 105.4±16.7 ml/min/1.73m2, respectively. Serum leptin level ..."
 
Vol 16, No 5 (2020) Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register Abstract  similar documents
I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova
"... .7% of patients had a low (49-125 points), 33.7% an average (126-154 points), and 40.6% of patients had a high ..."
 
Vol 21, No 1 (2025) The main predictors of seasonal blood pressure changes in patients with stable arterial hypertension in Moscow Abstract  similar documents
G. F. Andreeva, V. M. Gorbunov, Ya. N. Koshelyaevskaya, E. V. Platonova
"... pressure during ABPM were: 1) average daytime systolic BP (SBPd) 144.7 ± 1.4 mm Hg, nighttime (SBPn) — 126 ..."
 
Vol 18, No 4 (2022) Impact of the COVID-19 Pandemic on Myocardial Revascularization in Patients with Acute Coronary Syndrome in the Russian Federation Abstract  PDF (Eng)  similar documents
B. G. Alekyan, S. A. Boytsov, V. I. Ganyukov, E. M. Manoshkina
"... (by 28.6%); there was an increase in the average annual number of PPCI (by 12.6%), which was accompanied ..."
 
Vol 18, No 6 (2022) What is changing in the treatment of acute coronary syndrome in the Russian Federation? Abstract  similar documents
S. A. Boytsov, B. G. Alekyan, R. M. Shakhnovich, V. I. Ganyukov
"... .6%); there was an increase in the average annual number of primary PCI (by 12.6%); an absolute and relative increase ..."
 
Vol 19, No 1 (2023) Incidence and Severity of Acute Myocardial Injury after Thoracic Surgery: Effects of Nicorandil Abstract  similar documents
K. V. Protasov, O. A. Barahtenko, E. V. Batunova, E. A. Rasputina
"... .8;207.7) ng/mL; p<0.05]. The serum IMA decreased when taking nicorandil to a greater extent [-8.0 (-12.6; -2 ..."
 
Vol 17, No 3 (2021) Treatment and Secondary Prevention of Venous Thromboembolism in Real Clinical Practice Based on Health Care Professional Survey Abstract  similar documents
K. V. Lobastov, A. R. Navasardyan, I. V. Schastlivtsev
"... factors were 13.3% and events provoked by small persistent risk factors were 12.6%, while cancer ..."
 
Vol 7, No 1 (2011) ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov
"... not requiring propafenone (900-1200 mg/day) withdrawal were observed in 12,6% of patients. ..."
 
Vol 19, No 3 (2023) Association of polymorphic variants of CYP2C19, P2RY12, ITGB3, ITGA2 and eNOS3 genes with high residual platelet reactivity while taking clopidogrel and acetylsalicylic acid at different terms of myocardial infarction Abstract  similar documents
T. P. Pronko, V. A. Snezhitskiy, T. L. Stepuro, A. V. Kapytski
"... , on days 1-2 of MI (OR 6,5 (1,16-36,4), p=0,033), on days 28-30 of MI (OR 7,8 (1,26-48,0), p=0 ..."
 
Vol 7, No 5 (2011) HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY  similar documents
G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio
"... тромбоцитов (50±20% против 31±20%; p<0,0001), улучшение поток-зависимой вазодилатации (16,9±12,6% против 7,9±7 ..."
 
1 - 29 of 29 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)